Credelio for Dogs
No Prescription Required

Credelio is a monthly oral chewable containing lotilaner, an isoxazoline-class ectoparasiticide that controls fleas and ticks in dogs from 8 weeks of age and 4.4 lbs. It is manufactured by Elanco and available in five weight-based tablet strengths covering dogs up to 100 lbs.

Anipetshop is licensed under Australian APVMA regulations, which classify Credelio as a non-prescription veterinary product. Orders ship directly to customers in the United States, Canada, and the UK without requiring a prescription. The formulation, active ingredient, and dosage standards are identical to those dispensed at U.S. veterinary clinics.

Can You Buy Credelio for Dogs Without a Vet Prescription?

Yes, Credelio can be purchased without a vet prescription at Anipetshop. Whether a prescription is required depends on the country of sale, not the country where the order is delivered.

In the United States, the FDA classifies Credelio as a prescription-only veterinary medication. Domestic clinics and pharmacies require a valid veterinarian-client-patient relationship before dispensing it, which means a formal consultation and written authorization are required before purchase.

The APVMA classifies Credelio as a non-prescription veterinary product in Australia. No veterinary authorization is required to dispense it, and Australian-licensed pharmacies may supply it directly to customers.

Anipetshop operates under an Australian pharmacy license and is legally authorized to supply Credelio to customers in the United States, Canada, and the UK without requiring a prescription. The formulation, active ingredient (lotilaner), and dosage standards are identical to those available products in the US.

Explore the Credelion Chewable Formulation

Credelio là beef-flavored chewable tablet containing lotilaner, an isoxazoline-class ectoparasiticide. Each tablet delivers 30 days of systemic flea and tick protection following a single oral dose administered with food.

The formulation includes inactive ingredients such as pork liver powder, soy protein, barley, wheat, and lactose. Dogs with known sensitivities to any of these ingredients should not receive Credelio. Consult a veterinarian before use if your dog has a history of food allergies.

Formulation details for reference:

• Flavoring: Beef-flavored via pork liver powder and soy. The tablet contains no actual beef, which is relevant for dogs with confirmed beef protein allergies.
• Active ingredient: Lotilaner, at a minimum effective dose of 9 mg/lb (20 mg/kg). Dose is determined by body weight.
• Physical form: White to beige, round biconvex tablet. Texture is designed to support voluntary acceptance in most dogs.
• Storage: Store at or below 77°F (25°C) in original packaging. Short-term excursions between 41°F (5°C) and 104°F (40°C) are permitted.

Five Credilio packs are available at Anipetshop. Each pack contains 6 tablets, covering six months of monthly treatment:

Take the Correct Dosage

Credelio is dosed strictly by body weight, with a minimum effective dose of 9 mg/lb (20 mg/kg) of lotilaner. The five available tablet strengths are designed to cover dogs from 4.4 lbs to over 100 lbs.

The dosage table below matches each weight range to its corresponding tablet:

For dogs over 100 lbs (45.4 kg), combine tablets to meet the required minimum dose. Tablets should not be split, as dose consistency cannot be guaranteed.

Dogs near the upper limit of a weight band should move to the next higher strength at the next dose. A dog at 24.5 lbs (11.1 kg) dosed with the Orange pack (225 mg lotilaner) receives 9.2 mg/lb, just above the minimum effective dose of 9 mg/lb. A dog at 25.0 lbs (11.3 kg) given the same tablet receives exactly 9 mg/lb, leaving no margin if body weight increases before the next dose. Underdosing reduces plasma lotilaner concentration below the level required to maintain consistent ectoparasiticide activity across the full 30-day period.

Why Should Dog Owners Choose Credelio?

Credelio’s primary clinical advantage is speed of onset combined with a systemic mechanism that is unaffected by bathing or water exposure. It is approved for use in dogs from 8 weeks of age and 4.4 lbs (2 kg), covering a wider age range than some isoxazoline alternatives.

Clinical and pharmacokinetic properties that inform this choice:

• Kills fleas within 4 hours: Lotilaner reaches sufficient plasma concentration to begin killing fleas within 4 hours of administration, with near-complete efficacy recorded at 12 hours. This speed limits flea reproduction and reduces environmental contamination between treatment cycles.
• Eliminates ticks before pathogen transmission: Credelio eliminates black-legged ticks, American dog ticks, and lone star ticks within 48 hours of attachment. Ticks must attach to transmit most tick-borne pathogens, so a sub-48-hour kill window reduces transmission risk.
• Full 30-day coverage in one dose: A single dose maintains lotilaner plasma concentration above the minimum effective threshold for 30 days. No mid-cycle reapplication is required, and efficacy is not affected by bathing or water exposure.
• Safe from 8 weeks of age: Approval from 8 weeks and 4.4 lbs allows treatment during early puppyhood, a period when flea infestation can cause iron-deficiency anemia in small-breed dogs.

How Do Pet Owners Review Non-Prescription Credelio Online?

Credelio holds a 4.7 out of 5 rating on Influenster based on pet owner reviews. The most consistent observation across reviews is voluntary acceptance, including in dogs with a history of refusing oral medications.

One reviewer reported two years of use across two dogs, noting consistent flea and tick control and no refusal issues, including in a dog that had previously rejected similar chewable treatments.

Palatability is clinically relevant beyond owner convenience. A dog that refuses or partially consumes a chewable dose may receive less than the minimum effective concentration of 6 mg/kg lotilaner, reducing efficacy over the 30-day treatment period.

Order Credelio for Dogs Without a Vet Prescription at Anipetshop

Anipetshop is licensed under Australian APVMA regulations and supplies Credelio directly to customers in the United States, Canada, and the UK without requiring a prescription. No generic substitutes are stocked. Every order contains the original manufacturer formulation with the same active ingredient, lotilaner, at the same dosage standards as those dispensed at U.S. veterinary clinics.

Products available through Anipetshop:

• Source: Credelio is sourced from licensed manufacturers across Australia, and Europe. Supply chain origin is documented and traceable to the original manufacturer.
• Labeling: All products carry English-language labeling with full dosing instructions, active ingredient disclosure, and storage requirements.
• Shelf life: Stock is managed to ensure adequate remaining shelf life at the time of dispatch, so the product reaches full potency through the intended treatment period.
• No substitutes: No generic or reformulated alternatives are supplied. The lotilaner concentration and inactive ingredient profile match the original Elanco-manufactured product.

How Credelio Works on Dogs

Credelio delivers lotilaner systemically via oral administration. Once absorbed through the gastrointestinal tract into circulation, lotilaner is taken up by feeding fleas and ticks through the dog’s blood.

Food intake at the time of dosing significantly increases gastrointestinal absorption of lotilaner. Administering Credelio without food reduces bioavailability and may result in plasma concentrations falling below the minimum effective threshold of 20 mg/kg across the 30-day period.

Lotilaner blocks GABA-gated chloride channels in the nervous system of fleas and ticks. This disrupts inhibitory nerve signaling, causing uncontrolled neuronal firing, paralysis, and death. Mammalian GABA receptors differ structurally from those in insects and arachnids, which accounts for the selective toxicity to parasites at therapeutic doses in dogs.

Onset and duration of action by parasite type:

• Kills fleas within 4 hours: Lotilaner reaches flea-lethal plasma concentration within 4 hours of administration. Near-complete flea efficacy (approximately 100%) is recorded at 12 hours, limiting flea reproduction and environmental recontamination.
• Eliminates ticks within 48 hours: Black-legged ticks, American dog ticks, and lone star ticks are eliminated within 48 hours of attachment. This kill window is relevant because most tick-borne pathogens require extended attachment time to transmit.
• Sustained activity for 30 days: A single dose maintains lotilaner above effective plasma concentration for the full monthly cycle, covering both existing infestations and new parasite exposure.

How Should You Administer Credelio for Dogs?

Give one Credelio tablet orally once a month, with food or within 30 minutes after a meal. Lotilaner bioavailability drops significantly when administered in a fasted state, which can result in plasma concentrations falling below the minimum effective threshold before the 30-day cycle completes.

Step-by-step administration:

1. Confirm body weight before each dose. Select the tablet strength corresponding to your dog’s current weight. Growing dogs may move into a higher weight bracket between doses, requiring an upgrade in tablet strength to maintain the minimum effective dose of 9 mg/lb (20 mg/kg).
2. Administer with food. Give the tablet during a meal or within 30 minutes after feeding. Fasted administration reduces absorption and is not considered a valid dose for the full treatment period.
3. Confirm the full tablet is consumed. Watch the dog until the tablet is fully swallowed. A partially consumed tablet delivers less than the labeled dose and cannot be assumed to provide full 30-day protection.

If a dog refuses the tablet, place it in a small amount of food. Do not crush or split the tablet, as this compromises dose integrity and cannot guarantee the full lotilaner dose is delivered. If vomiting occurs within 2 hours of administration, redose with food as soon as possible. Administer every 30 days without exception: extending the interval creates a gap in systemic lotilaner coverage during which flea and tick activity is no longer suppressed.

Are There Any Side Effects of Credelio to Consider?

Yes. Credelio is associated with gastrointestinal, dermatological, and neurological adverse effects, with severity ranging from mild GI upset to seizures in predisposed dogs. The FDA has issued a class-wide alert for isoxazoline compounds, including lotilaner, regarding neurological adverse events.

Gastrointestinal and dermatological effects reported in clinical and post-market data:

• Vomiting and diarrhea: The most commonly reported adverse effects following oral lotilaner administration. Administering with food reduces but does not eliminate this risk.
• Decreased appetite and weight loss: Reported in a subset of dogs across treatment cycles. Monitor food intake in the first week following each dose.
• Skin irritation and hair loss: Includes pruritus, dermatitis, and localized alopecia. These effects are not fully understood mechanistically and should be reported to a veterinarian if persistent.
• Elevated BUN: Increased Blood Urea Nitrogen has been reported in post-market surveillance. Dogs with pre-existing kidney conditions should be assessed by a veterinarian before starting a lotilaner.

Dogs with a history of seizures or neurological conditions should not receive Credelio without prior veterinary clearance. Neurological signs associated with isoxazoline-class medications include muscle tremors, loss of coordination, and seizures. If any of these signs occur after dosing, discontinue use and contact a veterinarian immediately.

Are There Credelio Alternatives That Don’t Require a Vet’s Prescription?

Yes. Anipetshop supplies several isoxazoline-class and non-isoxazoline alternatives to Credelio, all available without a prescription under Australian APVMA regulations. The appropriate alternative depends on the parasite coverage required, treatment duration, and your dog’s individual health history. Consult a veterinarian if your dog has a seizure history before selecting any isoxazoline-class product.

Oral isoxazoline alternatives with flea and tick coverage:

• NexGard (afoxolaner): Monthly oral chewable manufactured by Boehringer Ingelheim. Covers fleas, black-legged ticks, American dog ticks, brown dog ticks, and lone star ticks.
• Simparica (sarolaner): Monthly oral chewable manufactured by Zoetis. Begins killing fleas within 3 hours, with tick efficacy within 8 hours.
• Bravecto (fluralaner): Single oral dose provides 12 weeks of flea and tick coverage, manufactured by MSD Animal Health. Reduces dosing frequency to four times per year.
• Simparica Trio (sarolaner + moxidectin + milbemycin oxime): Monthly oral chewable covering fleas, ticks, heartworm, and intestinal worms. Appropriate for dogs requiring combined parasite control in a single product.

FAQs

Is Credelio Safe for Puppies?

Yes, for puppies at least 8 weeks old and weighing 4.4 lbs (2 kg) or more. Puppies below either threshold should not receive lotilaner. The 56.25 mg tablet applies to dogs in the 4.4 to 6.0 lb range. Body weight should be verified before each monthly dose, as growing puppies may cross into a higher weight bracket and require an upgraded tablet strength to maintain the minimum effective dose of 9 mg/lb .

How Should Credelio Be Stored?

Store between 15°C and 30°C (59°F to 86°F) in the original packaging, away from moisture and direct sunlight. Bathrooms and laundry areas are unsuitable storage locations due to humidity exposure. Keep out of reach of children and other pets at all times.

What Precautions Apply Before Using Credelio?

Dogs with a history of seizures or neurological conditions should not receive Credelio without prior veterinary clearance. Lotilaner is an isoxazoline-class compound with a documented association with neurological adverse events in predisposed animals. Wash hands after handling the tablet and monitor the dog for at least 2 hours after the first dose.

Does Credelio Contain Allergens?

Yes. Credelio contains pork liver powder, soy protein, barley, wheat, and lactose. Dogs with confirmed sensitivities to any of these ingredients should not receive this product. An alternative flea and tick treatment without these excipients should be selected in consultation with a veterinarian.

Can Credelio Tablets Be Split?

No. Splitting compromises dose integrity and cannot guarantee delivery of the full 9 mg/lb (20 mg/kg) lotilaner dose. Dogs at the upper limit of a weight range should receive the next higher tablet strength, not a split portion of a larger tablet.

What Should I Do If My Dog Overdoses on Credelio?

Contact a veterinarian immediately. Do not wait for symptoms to appear before seeking guidance. Signs of lotilaner overdose may include tremors, ataxia, and behavioral changes, all of which require prompt veterinary assessment.

What if My Dog Misses a Dose?

Administer the missed dose with food as soon as it is identified, then resume the monthly schedule from that new date. Do not administer two doses within a short interval to compensate. A gap in dosing reduces systemic lotilaner coverage and allows flea and tick activity to resume.

Can Credelio Be Used for Heartworm Prevention?

No. Lotilaner has no activity against Dirofilaria immitis (heartworm). Credelio is labeled for flea and tick control only. Dogs requiring combined flea, tick, and heartworm coverage should consider Credelio Plus, which combines lotilaner with milbemycin oxime for heartworm prevention and intestinal worm control.

How Does Credelio Compare to NexGard, Simparica, and Bravecto?

All four are isoxazoline-class oral flea and tick treatments, but they differ in active ingredient, dosing interval, and onset speed. Credelio (lotilaner) and Simparica (sarolaner) both offer faster flea onset than NexGard (afoxolaner), with lotilaner and sarolaner reaching flea-lethal concentration within 4 and 3 hours respectively, compared to afoxolaner at 8 hours. Bravecto (fluralaner) is the only product in this group dosed every 12 weeks rather than monthly, which reduces annual dosing frequency from 12 to 4. All four carry the FDA class-wide isoxazoline safety alert and require veterinary clearance before use in dogs with a seizure history.